ENDOMETRIAL CARCINOMA (EC)
Clinical trials for ENDOMETRIAL CARCINOMA (EC) explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA (EC) trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA (EC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Cancer's genetic weakness in first human trial
Disease control OngoingThis is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…
Matched conditions: ENDOMETRIAL CARCINOMA (EC)
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New pill tested to boost immune system before cancer surgery
Knowledge-focused OngoingThis small, early-stage study is testing a new oral drug called TPST-1495 in patients with endometrial or colorectal cancer who are already scheduled for surgery. The goal is to see if taking the pill for one week before surgery changes the immune system's activity in the blood a…
Matched conditions: ENDOMETRIAL CARCINOMA (EC)
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC